Small cell lung cancer: biological and therapeutic aspects
- 31 January 1996
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 22 (1), 27-60
- https://doi.org/10.1016/1040-8428(94)00170-7
Abstract
No abstract availableThis publication has 92 references indexed in Scilit:
- Growth factor and peptide receptors in small cell lung cancerLife Sciences, 1993
- Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative groupEuropean Journal Of Cancer, 1993
- Natural interferon alfa as maintenance therapy for small cell lung cancerEuropean Journal Of Cancer, 1992
- Epirubicin in previously untreated patients with small cell lung cancer: A phase II study by the EORTC lung cancer cooperative groupEuropean Journal Of Cancer, 1992
- Teniposide as single drug therapy for elderly patients affected by small cell lung cancerEuropean Journal Of Cancer, 1992
- Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancerEuropean Journal Of Cancer, 1992
- Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II studyEuropean Journal Of Cancer, 1992
- Pilot study of teniposide in combination chemotherapy for small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Chemotherapy of small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Multiple neuropeptides mobilise calcium in small cell lung cancer: Effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensinBiochemical and Biophysical Research Communications, 1989